Hemoptysis: Difference between revisions

(7 intermediate revisions by 4 users not shown)
Line 34: Line 34:
*Massive = A single expectoration of ≥ 50cc '''OR''' >600cc/24h
*Massive = A single expectoration of ≥ 50cc '''OR''' >600cc/24h
**Rare, occurring in 1-5% of patients.
**Rare, occurring in 1-5% of patients.
*May differentiate from hematemesis with pH litmus paper
**Hemoptysis tends to be alkaline
**[[Hematemesis]] tends to be acidic, and stomach acid tends to turn bright red blood in stomach to brown/black fragments unless massive


==Management==
==Management==
Line 45: Line 48:
*Coagulopathy
*Coagulopathy
**[[FFP]]
**[[FFP]]
*Emergenct bronchoscopy or embolization for life-threatening hemorrhage
*Emergent bronchoscopy or embolization for life-threatening hemorrhage
*Nebulized [[TXA]] 500 mg tid<ref>Wand O, et al. Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial. Chest. DOI: https://doi.org/10.1016/j.chest.2018.09.026</ref>
**Pediatric: used in [https://www.emrap.org/episode/emrap2018june/case report]
*IV [[TXA]] may reduce in-hospital mortality, length of stay, and total healthcare costs.<ref>Kinoshita T, Ohbe H, Matsui H, Fushimi K, Ogura H, Yasunaga H. Effect of tranexamic acid on mortality in patients with haemoptysis: a nationwide study. Crit Care. 2019;23(1):347. Published 2019 Nov 6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836388/</ref>


===Massive===
===Massive===
#Angle head down with affected lung low
*Angle head down with affected lung low
#Consider angio embolization
*Consider angio embolization
#[[Intubate]] with >8.0 (for bronch)
*Consider [[intubation]] with >8.0 (for bronch)


==Disposition==
==Disposition==
Line 63: Line 69:
<references/>
<references/>
[[Category:Pulmonary]]
[[Category:Pulmonary]]
[[Category:Symptoms]]

Revision as of 19:12, 4 January 2020

Background

  • Coughing of blood that originates from respiratory tract below level of larynx
  • Death usually occurs from asphyxiation, not exanguination
  • Easy to confuse with epistaxis or oropharynx bleeding

Clinical Features

  • Coughing up blood

Differential Diagnosis

Hemoptysis

Evaluation

Workup

  • Imaging
    • CXR
      • Nml in 30% (most of whom end up having bronchitis)
    • Chest CT with IV contrast
      • Indicated for gross hemoptysis or suspicious CXR
    • Bronchoscopy
  • Labs
    • CBC
    • Coags
    • Sputum stain/culture
    • Chem (Cr)
    • T&S/T&C
    • Urinalysis (autoimmune)
    • ECG (pulmonary hypertension/PE)

Evaluation

  • Massive = A single expectoration of ≥ 50cc OR >600cc/24h
    • Rare, occurring in 1-5% of patients.
  • May differentiate from hematemesis with pH litmus paper
    • Hemoptysis tends to be alkaline
    • Hematemesis tends to be acidic, and stomach acid tends to turn bright red blood in stomach to brown/black fragments unless massive

Management

  • Patient Placement
    • Placing patient with affected lung down may actually worsen V-Q mismatch
    • Some advocate for prone positioning
  • Intubation
    • Use 8-0 tube to allow for subsequent bronchoscopy
    • If possible can selectively intubate the unaffected bronchus to prevent aspiration
      • After tube passes through cords rotate 90degrees left or right and advance
  • Coagulopathy
  • Emergent bronchoscopy or embolization for life-threatening hemorrhage
  • Nebulized TXA 500 mg tid[1]
  • IV TXA may reduce in-hospital mortality, length of stay, and total healthcare costs.[2]

Massive

  • Angle head down with affected lung low
  • Consider angio embolization
  • Consider intubation with >8.0 (for bronch)

Disposition

  • Gross hemoptysis:
    • Admit
  • Young patient (<40yr) with scant hemoptysis, normal CXR, no smoking history:
    • Discharge
  • Risk factors for neoplasm (even if CXR normal) or suspicious CXR:
    • Discuss with pulmonologist before discharge

References

  1. Wand O, et al. Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial. Chest. DOI: https://doi.org/10.1016/j.chest.2018.09.026
  2. Kinoshita T, Ohbe H, Matsui H, Fushimi K, Ogura H, Yasunaga H. Effect of tranexamic acid on mortality in patients with haemoptysis: a nationwide study. Crit Care. 2019;23(1):347. Published 2019 Nov 6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836388/